Keyphrases
Adjuvanted
12%
Blood Samples
14%
Child Safety
12%
Clinical Trial Phases
12%
Confidence Interval
14%
Conjugate Vaccine
17%
CpG 1018
12%
Cut-off Score
14%
Demographic Factors
14%
Dengue
25%
Diphtheria Toxoid
25%
Environmental Performance Management
12%
Expanded Program on Immunization
12%
Fever
16%
Geometric Mean Titer
13%
Growth Delay
12%
Immunization Schedule
12%
Immunogenic
16%
Immunogenicity
87%
Indonesia
55%
Indonesian
35%
Indonesian children
50%
Jakarta
38%
Local Reaction
16%
Malaysian Adults
37%
Motor Profile
12%
Multicenter Trial
12%
Parturient Women
12%
Phase I Study
15%
Phase II Study
16%
PLoS
12%
Primary Infection
25%
Randomized Clinical Trial
25%
Recombinant Vaccine
12%
Revaccination
18%
Risk Factors
15%
Salmonella Typhi (S. Typhi)
14%
Second Dose
14%
Serious Adverse Events
15%
Seroprevalence
25%
Socialization Skills
12%
Suckling
12%
Systemic Response
16%
Typhoid Fever
12%
Typhoid Vaccine
40%
Urban Dwelling
25%
Vaccination
21%
Vi Polysaccharide Vaccine
14%
Vi-DT
37%
Young children
14%
Pharmacology, Toxicology and Pharmaceutical Science
2,5-Dimethoxy-4-iodoamphetamine
12%
Adverse Event
41%
Chronic Disease
12%
Clinical Trial
15%
Conjugate Vaccine
50%
Dengue
25%
Developmental Delay
12%
Diphtheria
12%
Diphtheria Toxoid
25%
Diphtheria Vaccine
12%
Disease
13%
Haemophilus
12%
Hepatitis B
25%
Hepatitis B Antigen
6%
Immunogenicity
100%
Infection
16%
Influenza B
12%
Myalgia
11%
Neutralizing Antibody
15%
Normal Human
8%
Pandemic
16%
Polysaccharide
15%
Prevalence
18%
Primary Infection
25%
Prospective Cohort Study
12%
Randomized Clinical Trial
25%
Recombinant Protein
12%
Recombinant Vaccine
12%
Salmonella Enterica Serovar Typhi
12%
SARS Coronavirus
25%
Seroprevalence
25%
Stunting
12%
Subunit Vaccine
12%
Tropical Disease
12%
Typhoid Fever
18%
Typhoid Vaccine
26%
Vaccination Policy
63%
Vaccine
10%